Helen Torley is PRESIDENT AND CEO of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 733,719 shares of HALO, which is worth approximately $42.4 Million. The most recent transaction as insider was on Feb 15, 2023, when has been sold 6,892 shares (Common Stock) at a price of $49.2 per share, resulting in proceeds of $339,086. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 734K
0% 3M change
8.42% 12M change
Total Value Held $42.4 Million

Helen Torley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2023
SELL
Payment of exercise price or tax liability
$339,086 $49.2 p/Share
6,892 Reduced 1.09%
623,717 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
13,092 Added 2.03%
630,609 Common Stock
Feb 12 2023
SELL
Payment of exercise price or tax liability
$844,652 $48.92 p/Share
17,266 Reduced 2.72%
617,517 Common Stock
Feb 12 2023
BUY
Exercise of conversion of derivative security
-
32,794 Added 4.91%
634,783 Common Stock
Feb 10 2023
SELL
Payment of exercise price or tax liability
$805,663 $48.92 p/Share
16,469 Reduced 2.66%
601,989 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
31,281 Added 4.81%
618,458 Common Stock
Feb 09 2023
SELL
Open market or private sale
$504,000 $50.4 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Feb 08 2023
SELL
Open market or private sale
$513,600 $51.36 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Feb 08 2023
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Feb 07 2023
SELL
Open market or private sale
$512,600 $51.26 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Feb 07 2023
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Jan 19 2023
SELL
Open market or private sale
$524,099 $52.41 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Jan 19 2023
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Jan 18 2023
SELL
Open market or private sale
$510,500 $51.05 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Jan 18 2023
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Jan 17 2023
SELL
Open market or private sale
$506,700 $50.67 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Dec 15 2022
SELL
Open market or private sale
$577,500 $57.75 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Dec 15 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Dec 14 2022
SELL
Open market or private sale
$583,000 $58.3 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Dec 14 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Dec 13 2022
SELL
Open market or private sale
$588,800 $58.88 p/Share
10,000 Reduced 1.67%
587,177 Common Stock
Dec 13 2022
BUY
Exercise of conversion of derivative security
$146,600 $14.66 p/Share
10,000 Added 1.65%
597,177 Common Stock
Nov 17 2022
SELL
Open market or private sale
$521,500 $52.15 p/Share
10,000 Reduced 1.67%
587,177 Common Stock

Also insider at

DGX
QUEST DIAGNOSTICS INC Healthcare
HT

Helen Torley

PRESIDENT AND CEO
Secaucus, NJ

Track Institutional and Insider Activities on HALO

Follow HALOZYME THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO